Skip to main content

Advertisement

Table 3 Total healthcare resource utilization and costs

From: Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study

Measure 12 month post period 24 month post period
Total Patients 761 272
  Inpatient Hospitalization   
  Members with Hospitalization n,(%) 158 (20.8%) 85 (31.3%)
  Hospitalizations Per Member** 0.4 (± 0.9) 0.7 (± 1.4)
  0 [0 - 6] 0 [0 - 8]
Emergency Room Visits   
  Members with Visit n,(%) 236 (31.01%) 121 (44.49%)
  Visits Per Member** 0.6 (± 1.6) 1.3 (± 3.0)
  0 [0 - 30] 0 [0 - 42]
Outpatient Visits   
  Members with Visit n,(%) 760 (99.9%) 272 (100.0%)
  Visits Per Member** 35. (± 33.5) 68.6 (± 61.7)
  25 [0 - 320] 53 [9 - 698]
Pharmacy Claims   
  Members with Pharmacy Claim, n,(%) 761 (100.0%) 272 (100.0%)
  Pharmacy Claims Per Member** 45.99 (± 31.9) 98.60 (± 65.9)
  39 [1 - 214] 83 [4 - 366]
Total Healthcare Cost** $17,460 (± $33,437) $30,292 (± $67,230)
  $10,896 [$1,097 - $758,916] $18,106 [$2,859 - $1,060,087]
  Inpatient Hospitalization Cost** $4,585 (± $23,717) $8,978 (± $48,891)
  $0 [$0 - $562,430] $0 [$0 - $774,152]
  Emergency Room Visit Cost** $400 (± $2,433) $855 (± $4,312)
  $0 [$0 - $62,129] $0 [$0 - $68,565]
  Outpatient Cost** $5,713 (± $8,397) $9,673 (± $12,448)
  $2,724 [$0 - $91,816] $6,067 [$0 - $144,264]
  Pharmacy Cost** $6,762 (± $6,359) $10,787 (± $10,996)
  $4,253 [$829 - $72,703] $6,343 [$855 - $73,434]
  1. **Mean, standard deviation, median, [range].